26 Jan Safety of Opioids since the introduction of OxyNEO (Q13-03B)
Safety of Opioids since the introduction of OxyNEO (Q13-03B)
Manuscripts
Gomes T, Paterson JM, Mukati M, Henry D; Canadian Network for Observational Drug Effect Studies investigators. Retrospective analysis of trends in dispensing long-acting non–tamper-resistant oxycodone near the Canada–United States border. CMAJ Open. 2015 Apr 2;3(2):E231-5.
Gomes T, Mastorakos A, Paterson JM, Sketris I, Caetano P, Greaves S, Henry D,for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis. CMAJ Open. 2017 November 5(4); E800-E807.
Gomes T, Jain S, Paterson JM, Sketris I, Caetano P, Henry D, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Trends and uptake of new formulations of controlled-release oxycodone in Canada. Pharmacoepidemiol Drug Saf.2018 May;27(5):520-525.